What is it used for?
ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- benzgalantaminebenzgalantamine
- Form and strength
- TABLET, DELAYED RELEASE · 5 mg; TABLET, DELAYED RELEASE · 10 mg; TABLET, DELAYED RELEASE · 15 mgTABLET, DELAYED RELEASE · 5 mg; TABLET, DELAYED RELEASE · 10 mg; TABLET, DELAYED RELEASE · 15 mg
- Manufacturer / applicant
- ALPHA COGNITION, INC.ALPHA COGNITION, INC.
ZUNVEYL delayed-release tablets are enteric coated and available in the following strengths of benzgalantamine: 5 mg white, round, and convex, debossed with "B05" in grey 10 mg purple, round, and convex, debossed with "B10" in grey 15 mg …ZUNVEYL delayed-release tablets are enteric coated and available in the following strengths of benzgalantamine: 5 mg white, round, and convex, debossed with "B05" in grey 10 mg purple, round, and convex, debossed with "B10" in grey 15 mg …
Safety and clinical review
- Serious Skin ReactionsSerious Skin Reactions
- AnesthesiaAnesthesia
- Cardiovascular ConditionsCardiovascular Conditions
- Gastrointestinal ConditionsGastrointestinal Conditions
- Genitourinary ConditionsGenitourinary Conditions
- Neurological ConditionsNeurological Conditions
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is ZUNVEYL used for?
ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of ZUNVEYL should I ask about?
TABLET, DELAYED RELEASE · 5 mg; TABLET, DELAYED RELEASE · 10 mg; TABLET, DELAYED RELEASE · 15 mgTABLET, DELAYED RELEASE · 5 mg; TABLET, DELAYED RELEASE · 10 mg; TABLET, DELAYED RELEASE · 15 mg
Read the primary sourceWhat determines the price of ZUNVEYL?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using ZUNVEYL?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.